2013
DOI: 10.1038/cddis.2013.161
|View full text |Cite
|
Sign up to set email alerts
|

A critical role of toll-like receptor 4 (TLR4) and its’ in vivo ligands in basal radio-resistance

Abstract: Toll-like receptor-4 (TLR4) plays a critical role in innate and acquired immunity, but its role in radio-resistance is unknown. We used TLR4 knockout (KO,−/−) mice and gut commensal depletion methods, to test the influence of TLR4 and its' in vivo agonist on basal radio-resistance. We found that mice deficient in TLR4 were more susceptible to IR-induced mortality and morbidity. Mortality of TLR4-deficient mice after IR was associated with a severe and persistent bone marrow cell loss. Injection of lipopolysacc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
67
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 54 publications
(71 citation statements)
references
References 30 publications
3
67
0
Order By: Relevance
“…Previously, it has been reported that doses in the range of 0.075-2 Gy increased the expression of TLR4-MD2 in mouse macrophages (12). Additionally, TLR4 was shown to be involved in the induction of radiation resistance (19), cell proliferation and the promotion of radiation-induced lymphomas (20), as well as the promotion of reactive oxygen and nitrogen species (ROS/RNS) causing the aggravation of chronic inflammatory diseases (21). One of the novel activators of TLR4 is HMGB1 (22).…”
Section: Discussionmentioning
confidence: 98%
“…Previously, it has been reported that doses in the range of 0.075-2 Gy increased the expression of TLR4-MD2 in mouse macrophages (12). Additionally, TLR4 was shown to be involved in the induction of radiation resistance (19), cell proliferation and the promotion of radiation-induced lymphomas (20), as well as the promotion of reactive oxygen and nitrogen species (ROS/RNS) causing the aggravation of chronic inflammatory diseases (21). One of the novel activators of TLR4 is HMGB1 (22).…”
Section: Discussionmentioning
confidence: 98%
“…After different treatments, cells were marked with Annexin V-FITC and PI (propidium iodide) using an apoptosis detecting kit (Invitrogen, Canada) as described previously [37]. Samples were determined by FACS assays and the results were analyzed using CellQuest software (Becton Dickinson, San Jose, CA) [38].…”
Section: Methodsmentioning
confidence: 99%
“…Cells were labeled with Annexin V-FITC and propidium iodide (PI) using an apoptosis detecting kit (Invitrogen, Canada) as described previously [31]. Samples were determined by FACS assays and the results were analyzed using CellQuest software (Becton Dickinson, San Jose, CA) [32].…”
Section: Methodsmentioning
confidence: 99%